Tag Archives: antibody

COVID antibody drugs from Lilly and Regeneron won’t do much to boost their top lines: analysts

When Eli Lilly won emergency use authorization for its COVID-19 antibody drug, bamlanivimab, earlier this week, beating Regeneron to the finish line in a closely watched race, it was viewed as both good news and bad news. Now that Wall Street analysts have had a couple of days to digest the approval, some have concluded… Read More »

FDA Approves Inmazeb (atoltivimab, maftivimab and odesivimab-ebgn) Antibody Cocktail for Ebola (Zaire Ebolavirus)

TARRYTOWN, N.Y., Oct. 14, 2020 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced today that the U.S. Food and Drug Administration (FDA) approved Inmazeb (atoltivimab, maftivimab and odesivimab-ebgn) for the treatment of infection caused by Zaire ebolavirus in adult and pediatric patients, including newborns of mothers who have tested positive for the infection. “We are… Read More »

All about monoclonal antibody drugs — the experimental treatment that may have turned Trump’s COVID-19 around

Article content continued “It’s entirely possible that by the time you’re giving it, you’re giving it too late.” Medical technicians work at a drive-through COVID-19 testing facility at the Regeneron Pharmaceuticals company’s Westchester campus in Tarrytown, New York, September 17, 2020. Photo by Brendan McDermid/Reuters/File That Trump got something wholly experimental has raised eyebrows, but… Read More »

Antibody tests may help detect COVID-19 infection – if used at right time.

Scientists have analysed data from around the world to examine the accuracy of antibody tests for COVID-19, and have shown that the timing of testing is critical. The tests do not work accurately when administered at the wrong time. In the most comprehensive review of its kind of COVID-19 testing, researchers have examined all available… Read More »